What’s the current market cap for Agilon health stock?

Agilon health (AGL) has a market cap of $1.4B as of May 27, 2026.

What is the P/E ratio for Agilon health stock?

The price to earnings (P/E) ratio for Agilon health (AGL) stock is 0 as of May 27, 2026.

Does Agilon health stock pay dividends?

No, Agilon health (AGL) stock does not pay dividends to its shareholders as of May 27, 2026.

When is the next Agilon health dividend payment date?

Agilon health (AGL) stock does not pay dividends to its shareholders.

What is the beta indicator for Agilon health?

Agilon health (AGL) has a beta rating of 2.31. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy Agilon health stock | $AGL Share Price

13:30

15:10

16:45

18:25

20:00

About Agilon health

Agilon Health Inc is a healthcare services company that partners with primary care physicians to support value-based care for senior patients. The company provides a platform that enables physician groups to manage healthcare outcomes and costs through a Medicare-centric, capitated care model and long-term partnerships with community-based physicians.

Ticker

$AGL

Sector

Health

Primary listing

NYSE

Employees

856

Headquarters

Westerville, United States

Website

www.agilonhealth.com

Agilon health Metrics

BasicAdvanced

$1.4bn

-$21.38

2.31

Bulls say / Bears say

Adjusted EBITDA was $54 million in Q1 2026, up 162% from $21 million in Q1 2025, reflecting improved medical margin and strong ACO REACH performance. (Business Wire)

Net income rose to $49 million in Q1 2026 from $12 million a year earlier, marking a swing to profitability driven by disciplined execution and better quality incentives. (Business Wire)

The company raised its full-year 2026 guidance to $5.68–$5.805 billion in total revenues, $350–$400 million in medical margin, and $10–$40 million in adjusted EBITDA, underscoring management’s confidence in its value-based care model. (Business Wire)

Total membership on the platform declined 11% year-over-year to 536,000, including a 13% drop in Medicare Advantage members, due to market and payer exits that may constrain future growth. (Business Wire)

First-quarter revenue fell 7% year-over-year to $1.42 billion, reflecting lower membership that offset gains from improved pricing and risk score performance. (Business Wire)

agilon health received a non-compliance notice from the NYSE in November 2025 for failing to maintain a $1.00 average closing share price, forcing a 1-for-25 reverse stock split that may weigh on shareholder sentiment. (SEC)

Data summarised monthly by Lightyear AI. Last updated on 10 May 2026.

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $AGL

Capital at risk

Market open

Upcoming events

No upcoming events

Bulls say / Bears say

Adjusted EBITDA was $54 million in Q1 2026, up 162% from $21 million in Q1 2025, reflecting improved medical margin and strong ACO REACH performance. (Business Wire)

Net income rose to $49 million in Q1 2026 from $12 million a year earlier, marking a swing to profitability driven by disciplined execution and better quality incentives. (Business Wire)

First-quarter revenue fell 7% year-over-year to $1.42 billion, reflecting lower membership that offset gains from improved pricing and risk score performance. (Business Wire)

Data summarised monthly by Lightyear AI. Last updated on 10 May 2026.